Results demonstrated that high expression of UBE2L3 was correlated with advanced tumor stage, while no difference was observed between UBE2L3 level and other clinicpathological characteristics including gender, age, smoking, histopathology type as well as tumor differentiation. This evidence concerns the gene UBE2L3 and neoplasm.